AEMD:NSD-Aethlon Medical, Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 1.28

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

0.21M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-05 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

N/A

USD12.14B 32.01 N/A
PODD Insulet Corporation

N/A

USD10.37B 872.00 N/A
ABMD Abiomed, Inc

N/A

USD6.29B 27.11 22.11
BRKR Bruker Corporation

N/A

USD5.19B 29.26 N/A
TNDM Tandem Diabetes Care, Inc

N/A

USD3.66B N/A N/A
IART Integra LifeSciences Holdings ..

N/A

USD3.50B 77.02 N/A
WMGI Wright Medical Group N.V

N/A

USD3.39B N/A N/A
LVGO Livongo Health, Inc

N/A

USD2.79B N/A N/A
NUVA NuVasive, Inc

N/A

USD2.27B 41.19 N/A
LIVN LivaNova PLC

N/A

USD2.05B 77.40 N/A

ETFs Containing AEMD

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 33.33% 92% A- 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.33% 92% A- 95% A
Trailing 12 Months  
Capital Gain 47.13% 92% A- 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.13% 92% A- 94% A
Trailing 5 Years  
Capital Gain -89.33% 26% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -89.33% 23% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -24.99% 10% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.99% 10% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 66.35% 43% F 16% F
Risk Adjusted Return -37.67% 16% F 13% F
Market Capitalization 0.01B 21% F 13% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -2.79 59% F 75% C
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -178.97% 23% F 7% F
Return on Invested Capital -98.65% 21% F 8% F
Return on Assets -68.29% 16% F 4% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.32 89% B+ 88% B+
Short Percent 27.88% 6% F 10% F
Beta 0.41 70% C- 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector